Asclepius Premium Hospital Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 03-11-2024
- Paid Up Capital ₹ 0.30 M
as on 03-11-2024
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 25.37%
(FY 2023)
- Profit 100.00%
(FY 2023)
- Ebitda 232.17%
(FY 2023)
- Net Worth -0.00%
(FY 2023)
- Total Assets 5.58%
(FY 2023)
About Asclepius Premium Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Abhishek Misra, Amit Jaiswal, Rohit Agarwal, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85300UP2020PTC134174
- Company No.
134174
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Sep 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Varanasi, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Asclepius Premium Hospital?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohit Agarwal  | Director | 08-Sep-2021 | Current |
| Abhishek Misra | Director | 08-Sep-2020 | Current |
| Amit Jaiswal | Director | 08-Sep-2020 | Current |
| Nishant Chhajer | Director | 08-Sep-2021 | Current |
| Prankul Singhal | Director | 08-Sep-2021 | Current |
| Bharat Goswami | Director | 08-Sep-2021 | Current |
Financial Performance of Asclepius Premium Hospital.
Asclepius Premium Hospital Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.37% increase. The company also saw a substantial improvement in profitability, with a 100% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asclepius Premium Hospital?
In 2023, Asclepius Premium Hospital had a public holding of 66.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Oriana Hospital Private LimitedActive 8 years 9 monthsAmit Jaiswal and Rohit Agarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Asclepius Premium Hospital?
Asclepius Premium Hospital has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asclepius Premium Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asclepius Premium Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
